June Off to a Poor ...
Health Care: Drugs
AMAG Pharmaceuticals Inc. (AMAG: NASDAQ)
$13.58 -0.45 | -3.21%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 61.25M | 66.24M | 17.18M | 1.94M |
| Cost of Sales | 4.36M | 3.52M | -1.39M | -1.69M |
| Gross Operating Profit | 56.89M | 62.72M | 18.57M | 3.62M |
| Selling, General, and Administrative Expenses | 68.86M | 84.94M | 77.83M | 49.54M |
| Research & Development | 58.14M | 54.46M | 36.27M | 31.72M |
| Operating Income before D & A (EBITDA) | -70.11M | -76.68M | -95.53M | -77.63M |
| Depreciation & Amortization | 6.18M | 4.08M | 2.40M | 1.98M |
| Interest Income | 1.75M | 1.74M | 3.15M | 9.14M |
| Other Income - Net | -193.00K | -380.00K | 164.00K | -1.46M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -78.24M | -81.62M | -94.62M | -71.92M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | -78.24M | -81.62M | -94.62M | -71.92M |
| Income Taxes | -1.17M | -472.00K | -1.27M | -278.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -77.07M | -81.15M | -93.35M | -71.65M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -77.07M | -81.15M | -93.35M | -71.65M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -77.07M | -81.15M | -93.35M | -71.65M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-73.56M | -78.93M | -93.35M | -71.65M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -77.07M | -81.15M | -93.35M | -71.65M |
| Basic EPS from Continuing Ops. | -3.64 | -3.90 | -5.46 | -4.22 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -3.64 | -3.90 | -5.46 | -4.22 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -3.64 | -3.90 | -5.46 | -4.22 |
| Basic Normalized Net Income/Share | -3.47 | -3.79 | -5.46 | -4.22 |
| EPS fr Continuing Ops. | -3.64 | -3.90 | -5.46 | -4.22 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -3.64 | -3.90 | -5.46 | -4.22 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -3.64 | -3.90 | -5.46 | -4.22 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-3.47 | -3.79 | -5.46 | -4.22 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with AMAG
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- UserPelican Watch
- UserPART 1 JPMorgan 28th Annual...
- UserPART 1 JPMorgan 27th Annual...
- Userileana
- UserShawen Portfolio 1
- Userfiallo Portfolio 1
- UserTSimao Portfolio 1
- Usersggrimsley
Latest AMAG Headlines from TheStreet
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 03.09.12 | 05:03 am
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- More Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- The Next Big Thing In Biotech: 2012 Outlook
01.06.12 | 05:01 am - 5 Stocks Poised for Breakouts 11.07.11 | 09:11 am
- Next Step for Amag's Board: Fire CEO, Sell the Company. 10.21.11 | 11:10 am
- Biotech Stock Mailbag: Keryx Pharma 10.14.11 | 06:10 am
- Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos 10.10.11 | 10:10 am
- Spectrum Pharma Said to Make Bid for Allos 09.21.11 | 11:09 am
Press Releases for AMAG
- AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences - Business Wire 05.29.12 | 05:05 pm
- AMAG Pharmaceuticals Appoints William Heiden As President And Chief Executive Officer - Business Wire 05.09.12 | 04:05 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On May 1, 2012 At 4:30 P.m. ET To Discuss Financial Results For The Quarter Ended March 31, 2012 - Business Wire 04.24.12 | 04:04 pm
- AMAG Pharmaceuticals Announces A Positive CHMP Opinion For The Approval Of Ferumoxytol In Europe For The Treatment Of Iron Deficiency Anemia In Adult Patients With Chronic Kidney Disease - Business Wire 04.20.12 | 09:04 am
- AMAG Pharmaceuticals Announces Preliminary Results From Its Phase III Study Evaluating Feraheme Compared To IV Iron Sucrose In Patients With Iron Deficiency Anemia - Business Wire 03.07.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On March 7, 2012 At 4:30 P.m. ET To Discuss Feraheme Clinical Trial Results - Business Wire 03.06.12 | 04:03 pm
- AMAG Announces Fourth Quarter And Year End 2011 Financial Results - Business Wire 03.05.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Present At The 24th Annual ROTH Conference - Business Wire 03.02.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On March 5, 2012 At 4:30 P.m. ET To Discuss Financial Results For The Fourth Quarter And Year Ended 2011 - Business Wire 02.23.12 | 04:02 pm
- AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences - Business Wire 02.13.12 | 04:02 pm
Partner Headlines for AMAG
- AMAG Beats Riding on Feraheme Sales - Analyst Blog - Zacks 05.02.12 | 10:05 am
- AMAG Pharmaceuticals Reports Mixed Q4 Results - Benzinga 03.05.12 | 04:03 pm
- AMAG Pharmaceuticals Reports Mixed Q4 Results - Benzinga 03.05.12 | 04:03 pm
- Israel Englander's Stock Picks With Insider Purchases - Seeking Alpha 01.18.12 | 09:01 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
- McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23 - Benzinga 12.12.11 | 01:12 pm
- Mid-Day Update: Stocks Pare Some Early Losses; Unemployment Claims Lift Sentiment - NASDAQ 11.17.11 | 05:11 pm
- Loss Shrinks at AMAG, CEO Departs - Analyst Blog - Zacks 11.08.11 | 10:11 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.26.11 | 09:10 am
- Stocks Rally on European Debt Summit Optimism; December Crude Surges Over 2% - NASDAQ 10.21.11 | 04:10 pm
